Pages that link to "Item:Q1285808"
From MaRDI portal
The following pages link to Operating characteristics of the standard phase I clinical trial design. (Q1285808):
Displaying 7 items.
- A conversation with Nancy Flournoy (Q254418) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Cumulative cohort design for dose-finding (Q2455719) (← links)
- Group up-and-down designs for dose-finding (Q2492509) (← links)
- A study of the probit model with latent variables in Phase I clinical trials (Q5220814) (← links)
- Target toxicity design for phase I dose-finding (Q5880075) (← links)
- Performance Measures in Dose‐Finding Experiments (Q6085864) (← links)
